Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision

被引:59
作者
Soyka, Michael [1 ,2 ,3 ]
Kranzler, Henry R. [4 ,5 ]
Hesselbrock, Victor [6 ]
Kasper, Siegfried [7 ]
Mutschler, Jochen [1 ,8 ]
Moeller, Hans-Juergen [2 ]
机构
[1] Psychiat Hosp Meiringen, Meiringen, Switzerland
[2] Ludwig Maximilians Univ Munchen, Dept Psychiat, Munich, Germany
[3] Med Pk Chiemseeblick, Rasthausstr 25, D-83233 Bernau, Germany
[4] Univ Penn, Crescenz VAMC, Philadelphia, PA 19104 USA
[5] VISN 4 MIRECC, Philadelphia, PA USA
[6] Univ Connecticut Hlth, Farmington, CT USA
[7] Univ Vienna, Dept Psychiat Med, Vienna, Austria
[8] Univ Zurich, Psychiat Hosp, Zurich, Switzerland
关键词
Alcoholism; pharmacotherapy; acamprosate; baclofen; naltrexone; nalmefene; topiramate; carbamazepine; disulfiram; ondansetron; benzodiazepine; TRANSCRANIAL MAGNETIC STIMULATION; PSYCHIATRY WFSBP GUIDELINES; PLACEBO-CONTROLLED TRIAL; NATIONAL EPIDEMIOLOGIC SURVEY; DEEP BRAIN-STIMULATION; COGNITIVE-BEHAVIORAL TREATMENT; POSITRON-EMISSION-TOMOGRAPHY; INDUCED PSYCHOTIC DISORDER; GAMMA-HYDROXYBUTYRATE GHB; PITUITARY BETA-ENDORPHIN;
D O I
10.1080/15622975.2016.1246752
中图分类号
R749 [精神病学];
学科分类号
100204 [神经病学];
摘要
These practice guidelines for the biological treatment of alcohol use disorders are an update of the first edition, published in 2008, which was developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). For this 2016 revision, we performed a systematic review (MEDLINE/PUBMED database, Cochrane Library) of all available publications pertaining to the biological treatment of alcoholism and extracted data from national guidelines. The Task Force evaluated the identified literature with respect to the strength of evidence for the efficacy of each medication and subsequently categorised it into six levels of evidence (A-F) and five levels of recommendation (1-5). Thus, the current guidelines provide a clinically and scientifically relevant, evidence-based update of our earlier recommendations. These guidelines are intended for use by clinicians and practitioners who evaluate and treat people with alcohol use disorders and are primarily concerned with the biological treatment of adults with such disorders.
引用
收藏
页码:86 / 119
页数:34
相关论文
共 358 条
[1]
A Randomized Trial of Combined Citalopram and Naltrexone for Nonabstinent Outpatients With Co-Occurring Alcohol Dependence and Major Depression [J].
Adamson, Simon J. ;
Sellman, J. Douglas ;
Foulds, James A. ;
Frampton, Christopher M. A. ;
Deering, Daryle ;
Dunn, Alistair ;
Berks, John ;
Nixon, Lee ;
Cape, Gavin .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2015, 35 (02) :143-149
[2]
Reward-motivated learning: Mesolimbic activation precedes memory formation [J].
Adcock, R. Alison ;
Thangavel, Arul ;
Whitfield-Gabrieli, Susan ;
Knutson, Brian ;
Gabrieli, John D. E. .
NEURON, 2006, 50 (03) :507-517
[3]
Addolorato G, 2000, ALCOHOL CLIN EXP RES, V24, P67, DOI 10.1097/00000374-200001000-00011
[4]
Addolorato G, 1999, ALCOHOL CLIN EXP RES, V23, P1596
[5]
Baclofen efficacy in reducing alcohol craving and intake: A preliminary double-blind randomized controlled study [J].
Addolorato, G ;
Caputo, F ;
Capristo, E ;
Domenicali, M ;
Bernardi, M ;
Janiri, L ;
Agabio, R ;
Colombo, G ;
Gessa, GL ;
Gasbarrini, G .
ALCOHOL AND ALCOHOLISM, 2002, 37 (05) :504-508
[6]
Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study [J].
Addolorato, Giovanni ;
Leggio, Lorenzo ;
Ferrulli, Anna ;
Cardone, Silvia ;
Vonghia, Luisa ;
Mirijello, Antonio ;
Abenavoli, Ludovico ;
D'Angelo, Cristina ;
Caputo, Fabio ;
Zambon, Antonella ;
Haber, Paul S. ;
Gasbarrini, Giovanni .
LANCET, 2007, 370 (9603) :1915-1922
[7]
Dose-Response Effect of Baclofen in Reducing Daily Alcohol Intake in Alcohol Dependence: Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial [J].
Addolorato, Giovanni ;
Leggio, Lorenzo ;
Ferrulli, Anna ;
Cardone, Silvia ;
Bedogni, Giorgio ;
Caputo, Fabio ;
Gasbarrini, Giovanni ;
Landolfi, Raffaele .
ALCOHOL AND ALCOHOLISM, 2011, 46 (03) :312-317
[8]
Safety and Efficacy of Baclofen in the Treatment of Alcohol-Dependent Patients [J].
Addolorato, Giovanni ;
Leggio, Lorenzo .
CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (19) :2113-2117
[9]
Role of the GABAB receptor system in alcoholism and stress: focus on clinical studies and treatment perspectives [J].
Addolorato, Giovanni ;
Leggio, Lorenzo ;
Cardone, Silvia ;
Ferrulli, Anna ;
Gasbarrini, Giovanni .
ALCOHOL, 2009, 43 (07) :559-563
[10]
GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence [J].
Agabio, Roberta ;
Colombo, Giancarlo .
FRONTIERS IN NEUROSCIENCE, 2014, 8